Zean completes $40 million Series A+ round to accelerate development of myeloid cell engager pipeline | BlueRun Ventures Family
Focusing on unmet clinical needs in major disease areas such as cancer and autoimmune diseases.
蓝驰创投
@lanchi
不被定义
371 articles
Articles
AI Is Calling — Pick Up | BlueRun Ventures Is Hiring
Be the change you want to see.
BlueRun Ventures ranked No. 2 on ChinaVenture's 2024 list of Best Early-Stage Investment Firms, and also won awards including Best AI Sector Investor.
Let's Define the Future Together
How Can Tech Startups Seize Hong Kong's New Opportunities? | BlueRun Ventures Community Visits Hong Kong Economic and Trade Office in Beijing
Tides surge, sails unfurl.
AgiBot's Chief Scientist: "The Biggest Misunderstanding of Embodied AI Is Treating It Like a Large Language Model" | BlueRun Ventures Family Headline
Now is the best time to enter embodied AI.
Intelligence Surge: BlueRun Ventures' AI Portfolio Companies Launch Yet Another Wave of New Products | BlueRun Family Headlines
A day in AI, a year in the world.
Tian Cheng Technology Closes Nearly 100 Million RMB Series B Round to Accelerate Global Expansion of Embodied Intelligence Exoskeletons | BlueRun Family
Technology should serve everyone.
TimeTech Completes B+ Strategic Funding Round | BlueRun Ventures Portfolio
The Pragmatic Players in Low-Altitude Economy Reach a New Milestone
BlueRun Ventures Leads $120 Million Angel Round in Tashi Zhihang, Embarking on a New Journey in Embodied Intelligence | BlueRun Portfolio
Not just a "robotics company," but an "industry scenario solutions company."
Making Cars Intelligent Agents: Li Auto Unveils Next-Generation Autonomous Driving Architecture MindVLA | BlueRun Ventures Portfolio Headlines
MindVLA turns cars into dedicated chauffeurs — they understand what you say, see what's around them, and find their way anywhere!